
Jianli Dong, M.D., Ph.D.
Associate Professor,
Director, Molecular Diagnostics,
Department of Pathology;
Investigator, Sealy Center for Cancer Cell Biology
University of Texas Medical Branch
5.202 John Sealy Annex
301 University Boulevard
Galveston, TX 77555-0743
Office: (409) 772-4866
Fax: (409) 772-5683
Pager (409) 943-3258
jidong@utmb.edu
|
Professional Education
| Degree |
Institution |
Field of Study |
Graduation Year |
| M.D. |
First Military Medical University, China |
Medicine |
1985 |
| M.Sc. |
University of Toronto, Canada |
Molecular Biology |
1992 |
| Ph.D. |
University of Toronto, Canada |
Genetics |
1998 |
| Research Fellow |
Yale University School of Medicine |
Genetics |
1999 |
| Clinical Fellow |
Mount Sinai School of Medicine, New York |
Human Genetics |
2001 |
Honors
| 2006–2010 |
Research Award, Harry J. Lloyd Charitable Trust |
| 2005–2008 |
New Investigator Award, Cancer and Leukemia Group B Foundation |
| 2005–2008 |
Bill Walter III Melanoma Research Fund Award, Melanoma Research Foundation |
| 1992–1993 |
Connaught Scholarship, Canada |
| 1992 |
Honorable Mention, Institute of Medical Sciences, University of Toronto, Canada |
| 1992 |
Third Prize in Research, Toronto General Hospital, Canada |
| 1991–1992 |
Open Fellowships, University of Toronto, Canada |
Professional Affiliations
- American Society of Human Genetics
- Association for Molecular Pathology
- American Society for Microbiology
- American Association for Clinical Chemistry
- Fellow, National Academy of Clinical Biochemistry
- Society for Melanoma Research
Research Interests
(1) BRAF/MEK/ERK and p16/CDK/RB pathways in cancer biology. (2) Molecular diagnostics and translation research. Research and development of molecular biomarkers in clinical application.
Selected Publications
- Dong, J.; Asa, S.L.; Drucker, D.J. Islet cell and extrapancreatic expression of the LIM domain homeobox gene isl-1. Mol. Endocrinol. 5: 1633-1641; 1991.
- Dong, J.; Strome, R.; Hung, L.H.; Krause, H.M. A phosphorylation site in the Ftz homeodomain is required for activity. EMBO J. 17: 2308-2318; 1998.
- Dong, J.; Gailani, M.R.; Pomeroy, S.L.; Reardon, D.; Bale, A.E. Identification of PATCHED mutations in medulloblastomas by direct sequencing. Hum. Mutat. 16: 89-90; 2000.
- Dong, J.; Katz, D.R.; Eng, C.M.; Kornreich, R.; Desnick, R.J. Non-radioactive detection of the common Connexin 26 167delT and 35delG mutations and frequencies among Ashkenazi Jews. Mol. Genet. Metab. 73: 160-163; 2001.
- Dong, J.; Edelman, L.; Bajwa, A.M.; Kornreich, R.; Desnick, R.J. Familial dysautonomia: detection of the IKAPIVS20+6T®C and R696P mutations and frequencies among Ashkenazi Jews. Am. J. Med. Genet. 110: 253-257; 2002.
- Dong, J.; Phelps, R.G.; Qiao, R.; Yao, S.; Benard, O.; Ronai, Z.; Aaronson, S.A. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res. 63: 3883-3885; 2003.
- Manfredi, J.J.; Dong, J.; Liu, W.J.; Resnick-Silverman, L.; Qiao, R.; Chahinian, P.; Saric, M.; Gibbs, A.R.; Phillips, J.I.; Murray, J.; Axten, C.W.; Nolan, R.P.; Aaronson, S.A. Evidence against a role for SV40 in human mesothelioma. Cancer Res. 65: 2602-2609; 2005.
- Rotolo, S.; Diotti, R.; Gordon, R.E.; Qiao, R.F.; Phelps, R.G.; Dong, J. Effects on proliferation and melanogenesis by inhibition of mutant BRAF and expression of wild-type INK4A in melanoma cells. Int. J. Cancer 115: 164-169; 2005.
- Dong, J.; Olano, J.P.; McBride, J.W.; Walker, D.H. Emerging pathogens: challenges and successes of molecular diagnostics. Journal of Molecular Diagnostics 10: 185-197; 2008.
- Zhao, Y.; Zhang, Y.; Yang, Z.; Li, A.; Dong, J. Simultaneous knockdown of BRAF and expression of INK4A in melanoma cells leads to potent growth inhibition and apoptosis. Biochem Biophys Res Commun. 370: 509-13; 2008.
- Yang, Z.; Morrison, R.; Oates, C.; Sarria, J.; Patel, J.; Habibi, A.; Seyedjafari, R.; Hu, P.; Lennon, A.; Li, A.; Dong, J. HIV-1 Genotypic resistance testing on low viral load specimens using Abbott ViroSeq HIV-1 genotyping system. LabMedicine, 39: 671-672, 2008.
- Wang, Z.; Dong, J.; Eyzaguirre, E.J.; Tang, W.W.; Eltorky, M.A.; Qiu, S. Detection of human papilloma virus subtype 16 and P16 ink4a in invasive squamous cell carcinoma of the fallopian tube and concomitant squamous cell carcinoma in-situ of the cervix. Journal of Obstetrics and Gynaecology Research. 35: 385-389, 2009.
- Li, J.; Xu, M.; Yang, Z.; Li, A.; Dong, J. Simultaneous inhibition of MEK and CDK4 leads to potent apoptosis in human melanoma cells. Cancer Investigation. 28:350-6, 2010. PMID: 19968499.
- Xu, F.; Schwab, C.; Yang, X.; Weaver, S.; Li, A.F.; Sanborn, M.R.; Cloherty, G.A.; Dong, J. Low Prevalence of Non-subtype B HIV-1 Strains in the Texas Prisoner Population. J Mol Genetics. 2: 41-44, 2010.
- Bechert, C.J.; Payne, D.; Schnadig, V.; Dong, J. BK associated nephropathy in renal transplant patients. American Journal of Clinical Pathology, 133:242-250, 2010. PMID: 20093233.
- Clement, C.; Yang, Z.; Mayne, J.C.; Dong, J. HCV genotype and subtype distribution of patient samples tested at University of Texas Medical Branch in Galveston, Texas. J Mol Genetics. 2:36-40, 2010.
- Xu, F.; Schwab, C.; Yang, X.; Weaver, S.; Li, A.F.; Sanborn, M.R.; Cloherty, G.A.; Dong, J. Low prevalence of non-subtype B HIV-1 strains in the Texas prisoner population. J Mol Genetics. 2: 41-44, 2010.
- Li, Z.; Sheng, T.; Wan, X.; Li, T.; Wu, H.; Dong, J. Expression of HERV-K correlates with status of MEK-ERK and p16INK4A-CDK4 pathways in melanoma cells. Cancer Investigation, 28:1031-7, 2010. PMID: 20874005.
- Schlosshauer, P.W.; Deligdisch, L.; Penault-Llorca, F.; Fatemi, D.; Qiao, R.; Hao, S.; Yang, Z.; Sheng, T.; Pearl, M.; Dong, J. Loss of p16INK4A expression in low grade ovarian serous carcinomas. Int J Gynecol Pathol, 30:22-9, 2011. PMID: 21131838.
- Dong J.; Schwab, C. Simultaneous Knockdown of Mutant BRAF and Expression of INK4A in Melanoma Cells Leads to Potent Growth Inhibition and Apoptosis. In Rachael Morton R (ed). Treatment of Metastatic Melanoma. 2011. ISBN 978-953-307-574-7. InTech.
NIH Biosketch
|